ArticleInternational journal of hematology2003

Effects of the tyrosine kinase inhibitor imatinib mesylate on a Bcr-Abl-positive cell line: suppression of autonomous cell growth but no effect on decreased adhesive property and morphological changes.

Toshio Nishihara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.